1. Introduction {#sec1}
===============

Dementia is a syndrome characterized by progressive cognitive decline and significant interference in daily function [@bib1]. The first observable problems in daily life often concern the instrumental activities of daily living (IADL). IADL can be defined as "complex activities for which multiple cognitive processes are necessary," such as cooking, managing finances, and driving [@bib2]. Detecting functional decline along the continuum from normal aging to dementia is highly relevant for a number of reasons. First of all, subtle IADL problems may already be present in subjects with mild cognitive impairment (MCI) and predict progression to dementia [@bib3], [@bib4], [@bib5]. This suggests that assessment of IADL can be used to select MCI subjects at an increased risk for dementia [@bib6]. Once a diagnosis has been established, measuring IADL performance remains essential for the monitoring of clinical progression [@bib7]. Finally, IADL assessment plays a pivotal role in clinical trials, particularly in the evaluation of symptomatic treatment in dementia caused by Alzheimer\'s disease (AD) [@bib8], [@bib9], [@bib10].

IADL performance is often measured using proxy-based questionnaires [@bib11]. Unfortunately, most of these questionnaires suffer from serious limitations. They focus on everyday activities that are outdated and less relevant for patients in the early stages of dementia [@bib12]. Furthermore, psychometric properties such as reliability, validity, and responsiveness are often questionable or overlooked [@bib13]. Recent studies have pointed out that improvements in IADL instruments are necessary, especially for detecting IADL problems in MCI and the early stages of dementia [@bib14], [@bib15], [@bib16], [@bib17].

To overcome the aforementioned drawbacks of existing IADL scales, Sikkes et al. developed the Amsterdam IADL Questionnaire (A-IADL-Q). The A-IADL-Q is a 70-item proxy-based tool and was developed with input from clinicians, patients, and caregivers [@bib18]. Previous studies have reported good psychometric properties with respect to reliability, validity, responsiveness, and diagnostic accuracy in dementia [@bib19], [@bib20], [@bib21]. One disadvantage of the A-IADL-Q is its length, resulting in an administration time of 20 to 25 minutes. In addition, respondents often report that some items are redundant or unclear. To facilitate its administration and implementation on a wider scale, we aimed to design a short and more concise version of the A-IADL-Q.

The present article describes the development and validation of a short version of the A-IADL-Q (A-IADL-Q-SV). We aimed to select the most informative items, using a combined approach of quantitative and qualitative methods. We expected that the short version would maintain the good psychometric quality of the original A-IADL-Q. In addition, we expected that IADL scores based on the short version would differ between diagnostic groups across the spectrum from normal cognition (NC) to dementia.

2. Methods {#sec2}
==========

2.1. Subjects {#sec2.1}
-------------

We selected 1355 subjects with different levels of cognitive functioning, ranging from NC to dementia. Their study partner, mainly a spouse, relative, or friend, completed the A-IADL-Q. We included subjects from neurologic memory clinics of the VU University Medical Center (VUmc) Alzheimer Center, Amsterdam, The Netherlands (*n* = 1117), and the Alzheimer Center Rotterdam, The Netherlands (*n* = 32), and from the geriatric memory clinic of the VUmc, Amsterdam, The Netherlands (*n* = 102). All these subjects underwent a dementia assessment, including clinical history, medical and neurologic examination, screening laboratory tests, a neuropsychological test battery, and brain imaging [@bib22]. During this visit, study partners completed the A-IADL-Q on an iPad. Subjects\' diagnoses were made in a multidisciplinary diagnostic meeting, containing at least a neurologist or geriatrician [@bib3], [@bib22], [@bib23].

We included cognitively normal subjects (*n* = 104) from the Amsterdam site of the preclinAD cohort of the European Medical Information Framework for AD project. Inclusion criteria for this cohort were age ≥60, modified telephone interview for cognitive screening \>22; Geriatric Depression Scale \<11; Consortium to Establish a Registry for AD 10-word list delayed recall \>−1.5 standard deviation of age adjusted normative data; and Clinical Dementia Rating score of 0 with a score on the memory subdomain of 0 [@bib24], [@bib25], [@bib26], [@bib27]. During the baseline visit, study partners completed the A-IADL-Q on an iPad.

Data were collected between October 2012 and August 2016. All subjects gave written informed consent and all study partners gave oral informed consent. The Medical Ethical Committee of the VUmc approved the study.

2.2. The Amsterdam IADL Questionnaire {#sec2.2}
-------------------------------------

The original A-IADL-Q is a proxy-based scale with 70 items covering a broad range of cognitive IADL [@bib18]. The items can be divided into eight subcategories: household, administration, work, computer use, leisure time, appliances, transport, and other activities. The A-IADL-Q is computerized and has an adaptive approach as the items are tailored to individual responses (see [Fig. 1](#fig1){ref-type="fig"}). This results in a minimum of 47 and a maximum of 70 items for each respondent. Before the start, it is emphasized that the questionnaire addresses day-to-day problems caused by cognitive problems, such as memory, attention, or planning problems. Difficulty in performance is rated on a five-point Likert scale, ranging from "no difficulty in performing this task" to "no longer able to perform this task." Scoring is based on Item Response Theory (IRT): a paradigm linking responses to a test battery to an underlying construct (or latent trait) [@bib28]. For the A-IADL-Q, the construct underlying the items can be termed "IADL performance," that is, the latent trait reflects IADL impairment with higher estimated trait levels indicating more impairment.

Linking the probabilities of category-specific item responses to latent trait levels is based on an IRT model [@bib28]. For the A-IADL-Q, the graded response model (GRM) is used: a polytomous IRT model appropriate for items with ordinal response categories [@bib29]. In the GRM, each item is characterized by a discrimination parameter (α) and four extremity parameters (βs; the number of response categories minus 1). The discrimination (or slope) parameter indicates how well an item discriminates between individuals with differing trait levels: higher discrimination parameters suggest higher ability to differentiate. The extremity (or category threshold) parameters represent the trait levels that mark the transition between response categories (in terms of cumulative probabilities for endorsement) [@bib29]. An important advantage of IRT is that one\'s level of the latent trait can be estimated from any set of items for which the parameters are known. Therefore, IRT is able to handle missing data that may result from an adaptive approach. IRT is often preferred over classical scoring methods for scale development and refinement: it advances the development of more efficient scales by supporting item-reduction while preserving measurement precision [@bib30], [@bib31].

The following basic assumptions underlie the IRT framework: (1) unidimensionality, implying that a single latent trait underlies the items; (2) local independence, which implies independence of item responses conditional on the latent trait; and (3) monotonicity, implying that the probability of endorsing (a category-specific response to) an item should increase as the trait level increases [@bib32]. Previous work showed that the A-IADL-Q could be adequately described by a single latent factor and that the assumptions of local independence and monotonicity were met as well [@bib19]. Because the present study contains a larger and more heterogenic sample, we have assessed these basic assumptions again.

2.3. Procedures {#sec2.3}
---------------

We divided the total sample into a training (*n* = 677) and validation set (*n* = 678), to use independent samples for the development and validation of the short version. We randomly split the Alzheimer Center Rotterdam, the VUmc geriatric, and the cognitively healthy cohorts. We conducted an alternative split procedure for the VUmc Alzheimer Center cohort (*n* = 1117), as a subsample (*n* = 206) of this cohort was used for the validation of the original A-IADL-Q. We therefore assigned this entire subsample to the current training set. From the remaining subjects (*n* = 911), we randomly assigned 35% to our training set and 65% to our validation set, to ensure that both sets had equal group sizes.

### 2.3.1. Development procedure {#sec2.3.1}

Item selection was performed in the training set, using a stepwise procedure that combined missing data, IRT, and content aspects. As shown in [Fig. 1](#fig1){ref-type="fig"}, a response is scored as missing when (1) the particular task has not been performed because of other reasons rather than cognitive problems, or (2) the study partner does not know whether the subject has performed that particular task in the past 4 weeks. Items with higher percentages of missing responses give us a less direct view of cognitive IADL, and are thus less applicable for our goal. We therefore eliminated items with more than 80% overall missing data. Items with more than 60% missing data in all diagnostic groups were candidates for elimination.

#### 2.3.1.1. IRT analyses {#sec2.3.1.1}

We explored whether all items met the basic assumptions for IRT and eliminated items that did not meet these conditions. In the subsequent refitting rounds, we used IRT to identify items that contributed little unique information to the model, as reflected in either low item information values (an index representing the precision with which the trait is measured) or overlapping item information curves (IICs; a mapping of the item information to the domain of the trait indicating how the information is distributed over the trait) with other items. After each elimination round, the GRM was refitted and an overall fit assessment was performed. This resulted in new item parameters and IICs that were used in the succeeding refitting round.

#### 2.3.1.2. Content aspects {#sec2.3.1.2}

Comprehensibility was investigated in two ways: (1) by inspecting the comments that respondents provided in the "comment box" after completing the A-IADL-Q; and (2) performing thinking-out-loud interviews in a subsample of respondents (*n* = 17) while they were completing the A-IADL-Q. Items that were often commented as unclear or redundant, in either the comment box or interview, were candidates for removal. Furthermore, we investigated relevance and cultural applicability of all A-IADL-Q items with an online survey that we distributed among international experts. Between February 2016 and May 2016, we distributed the survey through contacts of the authors (R.J.J. and S.A.M.S.) via Qualtrics ([www.qualtrics.com](http://www.qualtrics.com){#intref0010}). All respondents (*n* = 33) were clinicians or researchers representing seven countries and had experience with the administration or cross-cultural validation of the A-IADL-Q. They were asked to rate the necessity of each original A-IADL-Q item for inclusion in the short version on a visual analogue scale ranging from 0 ("not necessary at all") to 100 ("very necessary").

### 2.3.2. Validation procedure {#sec2.3.2}

To confirm the quality of the final short version, we investigated missing data patterns, experts\' ratings, adherence to IRT assumptions, and the overall fit of the short version items in the validation set. We subsequently investigated internal consistency of the short version and concordance between sum-scores derived from the short and original version. To assess construct validity [@bib33], we investigated the relationship between the short version and measures of global cognition (Mini--Mental State Examination; MMSE [@bib34]) and daily function (Disability Assessment for Dementia; DAD [@bib35]), which were available for the VUmc Alzheimer Center cohort. Based on previous results [@bib19], we expected moderate-to-high concordance between the short version and MMSE and DAD scores. To assess interpretability of the short version, we investigated differences in scores between six diagnostic groups that should represent different trait levels: (1) NC; (2) subjective cognitive decline (SCD); (3) MCI; (4) dementia caused by AD (AD dementia); (5) dementia other than AD (non-AD dementia); and (6) another neurologic or psychiatric disorder than dementia (Other).

2.4. Statistical analyses {#sec2.4}
-------------------------

Statistical analyses were performed using R and SPSS version 20.0 [@bib36], [@bib37]. Statistical significance (for multiplicity corrections) was set at *P* \< .05.

### 2.4.1. Development analyses {#sec2.4.1}

Item selection was partly based on IRT modeling. We used a GRM with a logit link function [@bib29]. This model was fitted on the basis of approximate marginal maximum likelihood estimation [@bib38]. The latent trait was assumed to follow a standard normal distribution. We assessed unidimensionality by performing an eigenvalue decomposition on the matrix of robust (Spearman) correlations between the items. A difference approximation to the second-order derivatives along the eigenvalue curve (scree plot) was calculated. This acceleration-approximation indicates points of abrupt change along the eigenvalue curve [@bib39]. The number of eigenvalues before the point with the most abrupt change (the point with the maximum acceleration value) represents the number of latent dimensions that dominate the information content. Local independence was assessed by inspecting residual correlation matrices. We considered residual correlations \>0.25 as indicative of problematic item pairs. We evaluated the monotonicity assumption using Mokken scale analysis [@bib40]. Items that gave at least one significant violation of manifest monotonicity and had a crit value \>30 were considered to violate latent monotonicity [@bib41]. We assessed basic model fit by comparing nested models: we used a likelihood ratio test (LRT) to evaluate if the full GRM provided a better fit than a constrained GRM with equal slope parameters across items [@bib28].

### 2.4.2. Validation analyses {#sec2.4.2}

We fitted a GRM on the final set of retained items. Estimation and assumption evaluation for this model were performed as described previously. This model was also compared with a constrained GRM as a means of basic model fit assessment. In addition, we evaluated global fitness of the final model with the comparative fit index (CFI) and root mean square error of approximation (RMSEA) [@bib42]. Trait (or factor) scores were then based on empirical Bayes estimates: the mode of the posterior distribution of the trait given the retained items evaluated at the marginal maximum likelihood estimates. We calculated internal consistency of the retained items using a robust version of McDonald\'s omega [@bib43]. We examined concordance between sum-scores derived from the short and original versions, and between short version sum-scores and MMSE and DAD scores, using Kendall\'s *W* [@bib44]. To assess whether the short version scores differed between the diagnostic groups, we used a Kruskal-Wallis rank sum test on the trait scores followed by Dunn\'s pairwise test for multiple comparisons of mean rank sums (a nonparametric alternative to analysis of variance followed by post hoc tests) [@bib45]. Multiple testing correction was based on the Bonferroni method.

3. Results {#sec3}
==========

3.1. Sample and item characteristics {#sec3.1}
------------------------------------

The study sample consisted of subjects with NC (*n* = 104), SCD (*n* = 219), MCI (*n* = 138), AD dementia (*n* = 413), non-AD dementia (*n* = 235), and 246 subjects with other diagnoses. [Table 1](#tbl1){ref-type="table"} shows subject characteristics for the total sample and for the training and validation set separately. There were no age and gender differences between the two sets. The MCI group was slightly larger in the training set, whereas the non-AD dementia group was slightly larger in the validation set.

Missing responses on the item level in the training set ranged from 10.5% ("preparing sandwich meals") to 92.8% ("programming a video recorder"). Approximately half of the original version items (36/70) contained more than 50% missing data. Mean ratings from the 33 experts ranged from 23.9 ("programming a video recorder") to 86.9 ("paying when doing the shopping"), with an overall mean score of 62.3 (standard deviation = 14.9).

3.2. Development of the short version {#sec3.2}
-------------------------------------

[Fig. 2](#fig2){ref-type="fig"} provides a flowchart of the item selection procedure. Our first step included the removal of two items that violated the assumption of monotonicity, together with seven items that contained more than 80% missing data. After the second round, we removed 11 items with missing responses more than 60% in all diagnostic groups and contributing little information to the model (item information \<3.0). After the third round, we removed eight items that received low ratings of experts (mean rating \<50) and had often been commented on as either unclear or redundant by respondents. We thereafter removed six items with overlapping IICs and overlapping content with other items within the same activity category (e.g., "cooking" versus "preparing hot meals"). Of these overlapping pairs, we removed the one containing higher missing data and lower content rating. After the fourth round, we removed four items that were often perceived as unclear and showed overlapping IICs with more specific items (e.g., "looking for important things at home" versus "looking for his/her keys"). Finally, we removed two items because of disputable item characteristics and additional comments of experts. After this, we refitted the model with the remaining 30 items and concluded that further shortening was unnecessary. All 30 retained items in the training set were deemed to contribute substantially unique information to the latent trait. The full GRM improved fit on the constrained GRM (*LRT value* = 98.01, *df* = 29, *P* \< .001).

3.3. Validation of the short version {#sec3.3}
------------------------------------

The final selection of items can be found in column 1 of [Table 2](#tbl2){ref-type="table"}. This selection adheres to all assumptions underlying the IRT framework. The maximum acceleration factor on the consecutive eigenvalues of the robust correlation matrix occurs at the second eigenvalue (with a value of 1.26), implying that the first eigenvalue (with a value of 17.09) dominates the information content. Hence, a single latent dimension is sufficient. Moreover, no item pair sorted a residual correlation \>0.25 and no item displayed significant violations of manifest monotonicity. [Table 2](#tbl2){ref-type="table"} also presents information on missing percentages and the estimated GRM parameters based on the validation set. The last column shows the experts\' ratings. As can be seen, all retained items contain less than 60% missing data and most items (26/30) had less than 50% missing data in the validation set. The extremity parameters were spread along the latent trait continuum (ranging from −4 to +4), which is also illustrated by the IICs presented in [Fig. 3](#fig3){ref-type="fig"}. For most items, item information values were more than 3 (on a total information of 163.68). Finally, all short version items received medium-to-high ratings from experts.

The full GRM provided better fit on the validation data than the constrained GRM (*LRT value* = 6644.47, *df* = 29, *P* \< .001). The overall fit of the final model was considered good: CFI = 0.994, RMSEA = 0.032. Internal consistency of the short version was very high (robust McDonald\'s omega = 0.98). Concordance between the item sum-scores of the short version and the original version was also very high (Kendall\'s *W* = 0.97). Concordance with the MMSE (Kendall\'s *W* = 0.72) and DAD (Kendall\'s *W* = 0.87) was high.

[Table 3](#tbl3){ref-type="table"} presents the clinical characteristics of the different diagnostic groups within the validation set. [Fig. 4](#fig4){ref-type="fig"} represents the trait score distributions for each diagnostic group. It can be seen that this score seems to increase from NC to dementia. The variances of the trait scores were not equal between diagnostic groups. Hence, a nonparametric test was used to assess diagnostic group differences between latent trait scores as derived from the final GRM. The Kruskal-Wallis rank sum test indicated that the mean trait score ranks of the diagnosis groups indeed differed (*χ*^2^ = 187.01, *df* = 5, *P* \< .001). Pairwise comparisons (Dunn\'s test) with the Bonferroni correction indicated the following pairwise differences: (1) NC versus all other groups (all corrected *P* values \<.001); (2) SCD versus AD dementia, non-AD dementia, and Other group (all corrected *P* values \<.001); and (3) MCI versus AD dementia (corrected *P* value = .002).

4. Discussion {#sec4}
=============

We designed a short version of the A-IADL-Q containing 30 items. We thereby reduced administration time by approximately 10 minutes. We showed that, although significantly shorter, the A-IADL-Q-SV has maintained the psychometric quality of the original A-IADL-Q. We demonstrated adequate measurement precision along the entire spectrum of IADL functioning. Short version scores were in high concordance with the MMSE and DAD, which supports the construct validity of the A-IADL-Q-SV. We also found that the A-IADL-Q-SV could differentiate between various diagnostic groups with respect to IADL impairment.

The present study expands on previous work on the A-IADL-Q, which already demonstrated good psychometric quality of the scale [@bib18], [@bib19], [@bib20], [@bib21]. The A-IADL-Q-SV contains only the most informative items, and thereby possible "noise" caused by less informative or ambiguous items has been reduced. Because of its reduced length, the A-IADL-Q-SV may be perceived as a more user-friendly measure. The use of shorter tests is also encouraged from a psychometric point of view: a short form containing items of the same quality as the original form may yield less measurement error and thus be more reliable [@bib28]. Longer tests are more likely to suffer from acquiescence bias and missing responses. Using the A-IADL-Q-SV may overcome these test-length related drawbacks.

Our findings suggest that the A-IADL-Q-SV can already detect IADL problems in subjects with SCD and MCI, which is in line with previous studies that report subtle functional impairment in these groups [@bib46], [@bib47], [@bib48]. We found that IADL scores differed between subjects with NC and SCD. This is of particular interest because both groups are characterized by the absence of objective cognitive impairment, although SCD subjects may be at higher risk of developing dementia [@bib49]. The A-IADL-Q-SV might thus be able to detect subtle functional decline that appears in preclinical stages of dementia, suggesting that it could be a promising measure for clinical trials in these earliest stages [@bib10], [@bib50].

Strengths of this study include our large and heterogenic sample with subjects covering a broad range of the IADL spectrum along the continuum from normal aging to dementia. Another strength is the use of a validation set to replicate findings derived from the training set. After splitting the total sample, the training and validation set both contained more than 500 subjects, a number that is recommended for estimating accurate parameters based on the GRM [@bib51]. Finally, combining statistical methods with input from respondents and experts is an important strength of this study, as it preserved both the psychometric quality and clinical relevance of the A-IADL-Q-SV.

There are some limitations that should be considered. Among them are our relatively small NC group, because of the fact that most subjects were recruited via memory clinics. Secondly, previous studies have shown that proxy-based IADL measures may be confounded by respondent characteristics such as caregiver burden and depression [@bib52]. We did not take these characteristics into account in the present study. However, Sikkes et al. showed low correlations between the original A-IADL-Q, caregiver burden, and depression, indicating limited confounding by these variables [@bib19].

Further research is needed to examine whether the A-IADL-Q-SV is sensitive to changes over time *within* subjects. We will investigate the A-IADL-Q-SV longitudinally in subjects with MCI and early dementia to determine whether it could be an effective measure for monitoring disease progression and evaluating disease-modifying therapies. Because the research field is shifting toward preclinical stages of dementia, it is also relevant to further investigate the A-IADL-Q-SV in subjects with SCD and the relation between IADL scores and dementia biomarkers in this group.

To conclude, we developed the A-IADL-Q-SV, which is a concise instrument to efficiently measure functional decline in the early stages of dementia. The A-IADL-Q-SV has retained the good qualities of the original A-IADL-Q; hence, we expect the A-IADL-Q-SV to be a promising outcome measure for daily function in dementia research and clinical practice.Research in Context1.Systematic review: The Amsterdam IADL Questionnaire (A-IADL-Q) was developed to detect problems in instrumental activities of daily living (IADL) in subjects with incipient dementia. Previous validation studies have demonstrated good psychometric properties. However, a shorter version is desired to facilitate administration and implementation on a wider scale. We therefore aimed to design and validate a short version of the A-IADL-Q (A-IADL-Q-SV).2.Interpretation: We developed an A-IADL-Q-SV that consists of 30 items, resulting in an administration time of 10 to 15 minutes. The A-IADL-Q-SV has maintained the psychometric quality of the original version. We demonstrated adequate measurement precision along the entire spectrum of IADL functioning from normal aging to dementia.3.Future directions: The A-IADL-Q-SV will be investigated longitudinally in subjects with early stages of dementia, to determine whether it could be an effective measure for the monitoring of disease progression and evaluation of symptomatic treatments.
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![Example item of the A-IADL-Q, including response options and scoring. Abbreviation: A-IADL-Q, Amsterdam IADL Questionnaire.](gr1){#fig1}

![Flowchart of the item selection procedure that led to the short version of the Amsterdam IADL Questionnaire (A-IADL-Q). Abbreviations: IADL, Instrumental Activities of Daily Living; IRT, Item Response Theory.](gr2){#fig2}

![Item information curves of the 30 Amsterdam IADL items that resulted in the short version. The bold black line represents the total test information curve. The latent trait ranges from −4 (good IADL functioning) to +4 (poor IADL functioning). Abbreviation: IADL, instrumental activities of daily living.](gr3){#fig3}

![Short version latent trait scores for each diagnostic group. Latent trait scores reflect IADL functioning, with higher scores indicating poorer IADL functioning. Post hoc analyses gave the following significant pairwise differences: (1) NC versus all other groups; (2) SCD versus AD dementia, non-AD dementia, and Other group; and (3) MCI versus AD dementia. Abbreviations: AD, Alzheimer\'s disease; IADL, instrumental activities of daily living; MCI, mild cognitive impairment; NC, normal cognition; SCD, subjective cognitive decline.](gr4){#fig4}

###### 

Subject characteristics

                       Total sample (*n* = 1355)   Training set (*n* = 677)   Validation set (*n* = 678)   *P* value
  -------------------- --------------------------- -------------------------- ---------------------------- ---------------------------------------------
  Age, M (SD)          65.7 (9.7)                  66.1 (10.1)                65.3 (9.2)                   .146[∗](#tbl1fnlowast){ref-type="table-fn"}
  Gender, female (%)   602 (44.4%)                 301 (44.5%)                301 (44.4%)                  .981[†](#tbl1fndagger){ref-type="table-fn"}
  Diagnosis                                                                                                
   NC                  104 (7.7%)                  52 (7.7%)                  52 (7.6%)                    
   SCD                 219 (16.2%)                 116 (17.1%)                103 (15.2%)                  
   MCI                 138 (10.2%)                 84 (12.4%)                 54 (8.0%)                    
   AD dementia         413 (30.5%)                 209 (30.9%)                204 (30.1%)                  
   Non-AD dementia     235 (17.3%)                 100 (14.8%)                135 (19.9%)                  
   Other               246 (18.2%)                 116 (17.1%)                130 (19.2%)                  

Abbreviations: AD, Alzheimer\'s disease; MCI, mild cognitive impairment; NC, normal cognition; SCD, subjective cognitive decline; SD, standard deviation.

Tested using independent *t* test.

Tested using Pearson\'s chi-square test.

###### 

Final selection of the short version items, including their missing data percentages, GRM parameters, item information values, and content ratings by experts

  Item                                                  \% Missing   Item parameters   Item information   Expert rating                          
  ------ ---------------------------------------------- ------------ ----------------- ------------------ --------------- ------- ------- ------ ----
  1      Carrying out household duties                  12.1         1.830             −0.653             0.259           1.309   2.209   4.73   76
  2      Doing the shopping                             14.3         2.027             −0.597             0.481           1.206   1.732   4.93   79
  4      Buying the correct articles                    34.8         1.505             −0.209             0.795           1.249   1.282   2.57   73
  6      Cooking                                        33.8         2.236             −0.613             0.426           0.990   1.388   5.25   76
  9      Preparing sandwich meals                       10.0         2.454             0.643              1.602           2.266   2.524   5.82   60
  10     Making minor repairs to the house              53.1         2.330             −0.867             −0.013          0.510   0.897   5.28   60
  11     Operating domestic appliances                  8.3          2.120             −0.074             0.865           1.544   2.142   5.17   63
  12     Operating the microwave oven                   30.4         1.938             0.134              0.880           1.351   1.711   3.83   58
  16     Operating the coffee maker                     11.4         2.751             0.598              1.302           1.731   1.913   5.82   63
  17     Operating the washing machine                  42.0         3.662             0.584              1.254           1.533   1.610   7.71   58
  19     Paying bills                                   34.4         2.659             −0.467             0.417           0.717   0.904   5.55   83
  22     Using a mobile phone                           17.0         2.126             −0.416             0.531           1.148   1.658   5      76
  23     Managing the household budget                  45.0         2.884             −0.773             0.138           0.448   0.738   6.56   79
  25     Using electronic banking                       46.9         3.632             −0.320             0.285           0.500   0.560   7.12   66
  28     Using a pin code                               11.8         2.030             0.190              1.082           1.533   1.984   4.34   77
  29     Obtaining money from a cash machine            32.7         3.486             0.397              0.892           1.316   1.484   7.59   69
  30     Paying using cash                              15.6         2.665             0.415              1.288           1.712   2.257   6.59   72
  31     Making appointments                            17.4         1.945             −0.660             0.270           1.363   1.945   4.33   75
  32     Filling in forms                               24.8         2.516             −0.792             0.173           0.754   1.307   5.95   66
  33     Working                                        47.1         1.579             −0.965             −0.237          0.379   0.742   2.95   70
  35     Using a computer                               22.6         2.229             −0.718             0.193           0.846   1.418   5.47   68
  37     Emailing                                       44.0         3.100             −0.297             0.293           0.789   1.024   7.01   54
  39     Printing documents                             56.6         4.080             −0.059             0.653           0.814   0.857   8.3    70
  46     Operating devices                              16.4         3.374             −0.367             0.584           1.243   1.869   10.3   72
  47     Operating the remote control                   3.1          1.786             0.017              1.073           1.734   2.599   4.32   80
  57     Playing card and board games                   50.9         1.657             −0.462             0.556           1.194   1.662   3.49   62
  59     Driving a car                                  25.7         1.592             −0.351             0.569           1.015   1.300   2.93   76
  65     Using a sat-nav system                         51.6         2.421             −0.394             0.384           0.777   0.823   4.62   61
  66     Using public transport                         47.9         3.123             −0.071             0.420           0.878   1.200   7.01   83
  70     Being responsible for his/her own medication   27.7         1.478             −0.075             1.005           1.685   2.361   3.16   82

Abbreviations: GRM, Graded Response Model; α, discrimination parameter; β\'s, extremity parameters.

NOTE. Percentage missing, parameter estimates, and information characteristics are based on the validation set. Expert ratings were made per item on a visual analogue scale ranging from 0 to 100.

###### 

Clinical characteristics of different diagnostic groups in the validation set

                       NC (*n* = 52)   SCD (*n* = 103)   MCI (*n* = 54)   AD dementia (*n* = 204)   Non-AD dementia (*n* = 135)   Other (*n* = 130)
  -------------------- --------------- ----------------- ---------------- ------------------------- ----------------------------- -------------------
  Gender, female (%)   30 (57.7%)      43 (41.7%)        18 (33.3%)       111 (54.4%)               57 (42.2%)                    42 (32.3%)
  Age, M (SD)          70.5 (7.6)      62.8 (10.2)       69.8 (9.3)       66.9 (8.9)                66.5 (8.5)                    60.8 (9.9)
  MMSE score, M (SD)   NA              27.3 (2.2)        26.6 (2.1)       20.1 (4.8)                23.7 (4.4)                    25.3 (4.3)
  DAD score, M (SD)    NA              91.0 (12.6)       86.5 (14.3)      78.2 (20.6)               75.7 (25)                     76.6 (23.7)

Abbreviations: AD, Alzheimer\'s disease; DAD, Disability Assessment for Dementia (lower scores reflect more dysfunction in activities of daily living); MCI, mild cognitive impairment; MMSE, Mini--Mental State Examination (higher scores reflect better cognitive functioning); NA, not available for this cohort; NC, normal cognition; SCD, subjective cognitive decline; SD, standard deviation.
